Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis

Armstrong, Rachael E, Frith, Lucy ORCID: 0000-0002-8506-0699, Ulph, Fiona M and Southern, Kevin W ORCID: 0000-0001-6516-9083 (2020) Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis. International Journal of Neonatal Screening, 6 (2). 40-.

This is the latest version of this item.

	Text Southern et al final.docx - Author Accepted Manuscript Available under License : See the attached licence file. Download (1MB)
	Text Newborn_Screening_for_Cystic_Fibrosis (Book IJNS 2020).pdf - Published version Available under License : See the attached licence file. Download (7MB)
	Text Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis.pdf - Published version Download (1MB) \| Preview

Official URL: https://www.mdpi.com/2409-515X/6/2/40

Abstract

Newborn bloodspot screening for cystic fibrosis is a valid public health strategy for populations with a high incidence of this inherited condition. There are a wide variety of approaches to screening and in this paper, we propose that a bioethical framework is required to determine the most appropriate screening protocol for a population. This framework depends on the detailed evaluation of the ethical consequences of all screening outcomes and placing these in the context of the genetic profile of the population screened, the geography of the region and the healthcare resources available. View Full-Text

Item Type:	Article
Uncontrolled Keywords:	cystic fibrosis, newborn bloodspot screening, cystic fibrosis screen positive, inconclusive diagnosis (CFSPID), bioethics
Depositing User:	Symplectic Admin
Date Deposited:	18 Feb 2021 11:27
Last Modified:	18 Jan 2023 22:59
DOI:	10.3390/ijns6020040
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3115814